Thomas Beetham - Aug 1, 2022 Form 4 Insider Report for Magenta Therapeutics, Inc. (DNTH)

Role
Title: Chief Legal Officer and Secretary
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Thomas W. Beetham
Stock symbol
DNTH
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
4
Date filed
8/1/2022, 09:14 PM
Previous filing
Jun 6, 2022
Next filing
Dec 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNTH Stock Option (Right to Buy) Award $0 +75 K $0.00 75 K Aug 1, 2022 Common Stock 75 K $1.57 Direct F1

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is August 1, 2022.

Remarks:

Title: Chief Legal Officer and Secretary